Published in Bioorg Med Chem Lett on June 26, 2015
Effects of a novel β-lapachone derivative on Trypanosoma cruzi: Parasite death involving apoptosis, autophagy and necrosis. Int J Parasitol Drugs Drug Resist (2016) 0.75
Bacoside A Induces Tumor Cell Death in Human Glioblastoma Cell Lines through Catastrophic Macropinocytosis. Front Mol Neurosci (2017) 0.75
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
How mitochondria produce reactive oxygen species. Biochem J (2009) 13.03
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov (2009) 10.32
Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov (2004) 5.82
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal (2012) 5.65
Mitochondria: releasing power for life and unleashing the machineries of death. Cell (2003) 5.07
Physiological roles of mitochondrial reactive oxygen species. Mol Cell (2012) 5.05
Mitochondria and cancer. Nat Rev Cancer (2012) 4.81
Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov (2013) 4.72
Mitochondria, oxidative stress and cell death. Apoptosis (2007) 4.29
Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol (2007) 4.16
Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07
Redox regulation of cellular signalling. Cell Signal (1999) 3.65
Superoxide dismutase as a target for the selective killing of cancer cells. Nature (2000) 3.44
Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci (2010) 3.32
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem (2004) 3.14
Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal (2009) 2.33
Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci (2006) 2.22
Targeting mitochondria. Acc Chem Res (2008) 2.03
NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J Biol Chem (2000) 1.99
Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst (2000) 1.95
An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci U S A (2007) 1.92
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer (2014) 1.89
Mitochondrial dysfunction in cancer. Mitochondrion (2004) 1.77
Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol (2015) 1.68
Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat Neurosci (2012) 1.58
Reactive oxygen species: from health to disease. Swiss Med Wkly (2012) 1.52
Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J Am Chem Soc (2005) 1.50
Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. Cancer Res (1995) 1.44
Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol Carcinog (2012) 1.40
Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides. J Pharmacol Exp Ther (2006) 1.36
Targeting mitochondria with organelle-specific compounds: strategies and applications. Chembiochem (2009) 1.26
Mitochondrial reactive oxygen species and cancer. Cancer Metab (2014) 1.20
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments. Nat Commun (2014) 1.19
Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. Cell Rep (2012) 1.12
Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol Cancer (2012) 1.10
Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion (2012) 1.10
Mitochondrial structure, function and dynamics are temporally controlled by c-Myc. PLoS One (2012) 1.09
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers. Mol Cancer Ther (2013) 1.08
Mitochondrially targeted anti-cancer agents. Mitochondrion (2010) 1.08
Design of iron chelators with therapeutic application. Dalton Trans (2012) 1.06
β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells. Cell Death Dis (2014) 1.04
Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms. Bioorg Med Chem (2007) 1.02
Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells. Mol Med (1999) 0.98
Activation of the NRF2 signaling pathway by copper-mediated redox cycling of para- and ortho-hydroquinones. Chem Biol (2010) 0.97
Targeted delivery of doxorubicin to mitochondria. ACS Chem Biol (2013) 0.96
Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants. Crit Care Med (2007) 0.95
Mitochondria-penetrating peptides: sequence effects and model cargo transport. Chembiochem (2009) 0.93
Mitochondria as a target in treatment. Environ Mol Mutagen (2010) 0.92
Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate. ACS Chem Biol (2014) 0.91
Molecular vehicles for mitochondrial chemical biology and drug delivery. ACS Chem Biol (2014) 0.91
Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions. PLoS One (2014) 0.91
Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect. PLoS One (2015) 0.91
Mitochondrial targeting of radioprotectants using peptidyl conjugates. Org Biomol Chem (2006) 0.90
Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts. PLoS One (2010) 0.90
Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state. Mol Nutr Food Res (2009) 0.90
Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. Antioxid Redox Signal (2015) 0.89
Deciphering of mitochondrial cardiolipin oxidative signaling in cerebral ischemia-reperfusion. J Cereb Blood Flow Metab (2014) 0.87
Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B. Org Biomol Chem (2008) 0.86
Mitochondria as a pharmacological target: magnum overview. IUBMB Life (2013) 0.86
Allylic Amines as Key Building Blocks in the Synthesis of (E)-Alkene Peptide Isosteres. Org Process Res Dev (2012) 0.85
Autosis: a new addition to the cell death Tower of Babel. Cell Death Dis (2014) 0.85
Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondria. Org Biomol Chem (2013) 0.84
Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases. Curr Pharm Des (2014) 0.83
Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells. Mol Med (2000) 0.82
β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. Chem Biol Interact (2010) 0.82
The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma. PLoS One (2014) 0.82
Redox-active and redox-silent compounds: synergistic therapeutics in cancer. Curr Med Chem (2015) 0.78